9MW3011 Clinical Trials
2 recruitingDrug
Phase 12
Showing 1–2 of 2 trials
Recruiting
Phase 1
A Study of Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of 9MW3011 in Patients With Polycythemia Vera
Polycythemia Vera
Mabwell (Shanghai) Bioscience Co., Ltd.108 enrolled6 locationsNCT06752746
Recruiting
Phase 1
A Multiple Ascending Dose Study of 9MW3011 in Patients With Non-transfusion-dependent β-thalassemia
Beta-Thalassemia
Mabwell (Shanghai) Bioscience Co., Ltd.40 enrolled2 locationsNCT06772766